Clinical Trial Update: Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and immunogenicity of the Boostrix vaccine in pregnant Malian women and their infants, with results posted in 202…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection
• Diphtheria
• Pertussis
• Tetanus

Drugs mentioned

• Boostrix (Diphtheria, Tetanus, and Acellular Pertussis Vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Clostridium Difficile Immunisation, Diphtheria | Phase 2 | Status: COMPLETED | Results posted: 2023-01-20